X-Chromosome Reactivation Drives Sex-Specific Bile Acid Homeostasis via Epigenetic Regulation of ASBT

Brett Christiansen· Mar 26, 2026

Mechanism: In aged females, X-chromosome reactivation boosts KDM6A/DDX3X, increasing FXR and ASBT to maintain healthy bile acid composition. Readout: Readout: This leads to extended lifespan in females, while aged males, lacking this boost, show altered bile acids and reduced longevity.

Hypothesis

With age, the inactive X chromosome in females undergoes epigenetic remodeling that reactivates a subset of X-linked genes encoding chromatin modifiers and transcription factors. These reactivated regulators, such as KDM6A (UTX) and DDX3X, enhance hepatic expression of the farnesoid X receptor (FXR) and thereby increase transcription of the ileal bile acid transporter ASBT (SLC10A2). Consequently, older females maintain higher bile acid reabsorption efficiency, preserving a bile acid pool that favors activation of longevity pathways (e.g., TGR5‑cAMP signaling) and limits accumulation of cytotoxic bile acids like deoxycholic acid. In males, who lack a second X chromosome, this regulatory boost is absent, leading to an age‑related decline in ASBT activity, altered bile acid composition, and accelerated senescence. This mechanism explains the female longevity advantage without invoking gonadal hormones.

Testable Predictions

X‑linked regulator expression – In liver and intestine of aged female mice, Kdm6a and Ddx3x mRNA and protein levels will be significantly higher than in age‑matched males; silencing Kdm6a in female hepatocytes will reduce Fxr and Asbt mRNA (qPCR, Western blot) and decrease bile acid reabsorption measured by fecal bile acid excretion.
Chromatin state – ChIP‑seq for H3K27ac and H3K4me3 at the Fxr and Asbt promoters will show greater enrichment in livers of old females versus old males; this enrichment will be lost after Kdm6a knockdown.
Bile acid phenotype – Aged female mice will exhibit a higher proportion of conjugated, hydrophilic bile acids and lower levels of secondary cytotoxic bile acids (LC‑MS metabolomics). Male mice will show the opposite shift, which can be rescued by hepatic overexpression of Kdm6a.
Longevity read‑out – Female mice with intestinal‑specific Asbt overexpression will extend median lifespan beyond controls, whereas male mice with the same overexpression will gain a smaller or negligible benefit, indicating that the effect is contingent on the X‑linked regulatory context.
Human correlative data – In publicly available GTEx data, expression of X‑linked KDM6A and DDX3X will correlate positively with FXR target genes and ASBT in liver samples from females over 60 years old, but not in males of the same age.

Falsifiability

If aged females show no increase in Kdm6a/Ddx3x expression, or if knocking down these factors fails to alter Fxr/Asbt expression or bile acid composition, the hypothesis is refuted. Likewise, if bile acid pools and longevity outcomes are unchanged by manipulating ASBT independently of X‑linked regulator status, the proposed mechanistic link is invalid.

Hypothesis

Testable Predictions

X‑linked regulator expression – In liver and intestine of aged female mice, Kdm6a and Ddx3x mRNA and protein levels will be significantly higher than in age‑matched males; silencing Kdm6a in female hepatocytes will reduce Fxr and Asbt mRNA (qPCR, Western blot) and decrease bile acid reabsorption measured by fecal bile acid excretion.

Chromatin state – ChIP‑seq for H3K27ac and H3K4me3 at the Fxr and Asbt promoters will show greater enrichment in livers of old females versus old males; this enrichment will be lost after Kdm6a knockdown.

Bile acid phenotype – Aged female mice will exhibit a higher proportion of conjugated, hydrophilic bile acids and lower levels of secondary cytotoxic bile acids (LC‑MS metabolomics). Male mice will show the opposite shift, which can be rescued by hepatic overexpression of Kdm6a.

Longevity read‑out – Female mice with intestinal‑specific Asbt overexpression will extend median lifespan beyond controls, whereas male mice with the same overexpression will gain a smaller or negligible benefit, indicating that the effect is contingent on the X‑linked regulatory context.

Human correlative data – In publicly available GTEx data, expression of X‑linked KDM6A and DDX3X will correlate positively with FXR target genes and ASBT in liver samples from females over 60 years old, but not in males of the same age.

Falsifiability